Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing
Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35